1.695USD+14.92%Mkt Cap: 118.30M USDP/E: —Last update: 2026-06-01
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap118.30M USD
Enterprise Value183.13M USD
Revenue (TTM)151.64M USD
Gross Profit72.31M USD
Net Income (TTM)-39.00M USD
Revenue/Share2.231 USD
Last Price1.695 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees658
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.57
PEG—
EV/EBITDA-7.10
EV/Revenue1.21
P/S0.71
P/B8.06
EPS (TTM)-0.54
EPS (Forward)-0.34
52W Range
0.800022% of range4.850
52W High4.850 USD
52W Low0.8000 USD
Profitability
Gross Margin48.48%
Oper. Margin-26.11%
EBITDA Margin-17.00%
Profit Margin-26.15%
ROE-174.27%
ROA-27.55%
Growth
Revenue Growth7.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.37M USD
CapEx (TTM)801.00K USD
FCF Margin-3.02%
FCF Yield-3.87%
Net Debt72.17M USD
Net Debt/EBITDA-2.80
Balance Sheet
Debt/Equity4.04
Current Ratio1.67
Quick Ratio1.03
Book Value/Sh0.1910 USD
Cash/Share0.1900 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.333 USD
Target Range3.000 USD – 7.000 USD
# Analysts3
Ownership
Shares Out.69.59M
Float30.46M
Insiders32.19%
Institutions59.86%
Short Interest
Short Ratio3.8d
Short % Float28.06%
Short % Out.13.85%
Shares Short9.64M
Short (prev mo.)10.91M
Technical
SMA 501.503 (+12.8%)
SMA 2002.017 (-16.0%)
Beta1.13
S&P 52W Chg27.70%
Avg Vol (30d)2.64M
Avg Vol (10d)3.24M
Technical Indicators
RSI (14)51.5
MACD-0.0734
MACD Signal-0.0770
MACD Hist.+0.0036
BB Upper2.153 USD
BB Middle1.492 USD
BB Lower0.8317 USD
BB Width88.55%
ATR (14)0.1662 USD
Vol Ratio (20d)0.39x